Sep 2026
Clinical outcomes of dynamic [18F]-FDG PET in focal epilepsy: a prospective early observational study.
BACKGROUND AND PURPOSE Standard static 18F-fluorodeoxyglucose PET (sPET) frequently registers normal metabolism in patients with focal drug-resistant epilepsy (DRE), limiting its utility for identifying the epileptogenic zone (EZ) for epilepsy surgery. Dynamic FDG-PET (dPET), which quantifies the rate of glucose uptake...
M. Quigg, P. Chernyavskiy, William Terrell et al.
· AJNR. American journal of ne... · 0 citations